Omnicom Group Inc.
Close on Nov 20, 2026Market cap $23.24BP/E –Yield 3.40%
Omnicom Pharmaceuticals & Health Client Revenue Mix by Quarter
Pharmaceuticals & Health Client Revenue Mix (%)
Omnicom Pharmaceuticals & Health Client Revenue Mix: 18.0% in Q3 2026, up 2.0 pts from a year earlier.
Where the Q3 2026 figure comes from
Source: SEC Form 10-Q (period ended 2026-09-30, filed 2026-10-23) ↗
Omnicom's largest client vertical (~16%–17% of revenue), reported across quarterly investor presentations and Form 10-K/10-Q MD&A.
quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Cite this data
StockData. (2026). Omnicom Pharmaceuticals & Health Client Revenue Mix (%), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Omnicom SEC filings and investor materials. https://stockdatahq.com/stocks/omc/kpis/client-ind-pharma-pct
See every metric in the Omnicom KPI table. Data updated Nov 15, 2026.
See a number that looks wrong?